Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Effect of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycanS Frankenburg, V Leibovici, N Mansbach, et al.
Israel Journal of Medical Sciences|January 1, 1994
Serial study of the immune response of an individual with exacerbated simple cutaneous leishmaniasisS N Klaus, S Frankenburg, A Gross, et al.
Clinical and Experimental Dermatology|January 1, 1993
Unusually extensive disease caused by Leishmania major parasitesD A Vardy, S Frankenburg, M Goldenhersh, et al.
Cellular Immunology|April 15, 1988
Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitroM Resnick, N Roguel, H Bercovier, et al.
Clinical and Experimental Dermatology|September 1, 1995
Imbalance of immune responses in patients with chronic and widespread fungal skin infectionV Leibovici, R Evron, O Axelrod, et al.
Parasite Immunology|July 1, 1983
The cellular and humoral immune response in subjects vaccinated against cutaneous leishmaniasis using Leishmania tropica major promastigotesM S Green, J D Kark, C L Greenblatt, et al.
Vaccine|June 1, 1996
Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccineS Frankenburg, O Axelrod, S Kutner, et al.
Clinical and Experimental Immunology|July 28, 2015
Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cellsA Pato, G Eisenberg, A Machlenkin, et al.
British Journal of Cancer|February 19, 2004
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanomaM Lotem, E Shiloni, I Pappo, et al.
Protein Expression and Purification|March 9, 2004
Production and purification of melanoma gp100 antigen and polyclonal antibodiesY Gelbart, S Frankenburg, Y Pinchasov, et al.
Pageof 5